PAR-23-063: Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2022.
National Institutes of Health offered grants of up to $1.5 million to small businesses. Applications closed on May 28, 2025.
From the official notice on Grants.gov, last changed December 20, 2022. Checked November 7, 2026.
- Award ceiling$1.5 million
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeP20
- Clinical trialsOptional
- Funded byNIGMS
- Median yearly award$273,875
- Typical project length10 years
- P20, Exploratory Grant. Planning or building a research center or program. Other open P20 notices.
Projects funded under PAR-23-063 were run by National Institute of General Medical Sciences (NIGMS, 27 projects). Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PAR-23-063 in the NIH Guide.
Other notices with this title
| Notice | Posted | Deadline | Status |
|---|---|---|---|
| PAR-22-163 | April 19, 2022 | Closed September 27, 2022 | Closed |
Key dates
| Posted | December 20, 2022 |
|---|---|
| Deadline | May 28, 2025 |
| Archived by Grants.gov | July 3, 2025 |
Who can apply
This opportunity was open to small businesses.
- Small businesses
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See full Funding Opportunity Announcement for additional details on eligibility
Is this a realistic fit?
- Projects NIH funded under this notice had a median yearly award of $273,875; it allows up to $1.5 million per award.
- Most of the program's money (80% over five years) went to colleges and universities.
- No cost sharing or match is required.
What the grant funds
The Centers of Biomedical Research Excellence (COBRE) program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions through awards for three sequential five-year phases. The purpose of the COBRE Phase 2 award is to strengthen successful COBRE Phase 1 centers established in Phase 1 through further improvements to research infrastructure and the continued development of a critical mass of investigators with shared scientific interests who are able to compete effectively for independent research funding and further improvements to research infrastructure at the institution.
Funded under PAR-23-063 so far
NIH funded 27 projects under PAR-23-063 in fiscal 2024 to 2026, at 26 institutions. The median yearly award was $273,875.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Core A - Administrative Core | University of Nevada Reno | 2026 | $632,877 |
| Phase 2 Center of Biomedical Research Excellence in Acute Care Research and Rural Health | Mainehealth | 2026 | $2.7 million |
| An initial test of biobehavioral mechanisms of sleep health alterations in the context of adolescent cannabis use using objective methods | Emma Pendleton Bradley Hospital | 2026 | $199,064 |
| University of New Mexico Center for Metals in Biology and Medicine | University of New Mexico Health Scis Ctr | 2026 | $2.3 million |
| Intervention Support Core | University of Montana | 2026 | $379,423 |
| COBRE-DIABETES | University of Hawaii at Manoa | 2026 | $2.3 million |
| Oklahoma Center for Microbial Pathogenesis and Immunity | University of Oklahoma HLTH Sciences Ctr | 2026 | $2.2 million |
| Molecular Mechanisms | LSU Pennington Biomedical Research Ctr | 2026 | $475,916 |
Who has won Biomedical Research and Research Training grants before
From fiscal 2021 to 2025, Biomedical Research and Research Training (93.859) awarded $15 billion across 11,631 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Leland Stanford Junior University | California | 186 | $290 million |
| Regents of the University of Michigan | Michigan | 226 | $268 million |
| University of California, San Diego | California | 198 | $264 million |
| Yale Univ | Connecticut | 195 | $250 million |
| University of Wisconsin System | Wisconsin | 169 | $241 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PAR-23-063 still open?
No. It closed on May 28, 2025.
Who can apply for Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)?
National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)?
Closed May 28, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $1.5 million each.
Who has been funded under PAR-23-063?
NIH RePORTER lists 27 projects funded under PAR-23-063 in fiscal 2024 to 2026, at 26 institutions. The most were at University of Oklahoma HLTH Sciences Ctr, University of Nevada Reno, Mainehealth.
Who has won Biomedical Research and Research Training grants before?
The largest recipients over five fiscal years were The Leland Stanford Junior University, Regents of the University of Michigan, University of California, San Diego. The program made 11,631 awards worth $15 billion in that time.
Similar open grants
- Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
- Community-Partnered Nursing Research Centers (P20 Clinical Trial Optional)
- Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)